Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus Infections
A Research Study Examining the Effectiveness of Distant Activation of ACE Pigments Associated With Recurrent Human Herpes Simplex Virus-Induced Skin Lesions.
1 other identifier
observational
500
0 countries
N/A
Brief Summary
The research question to be addressed is whether indirect phototherapy based activation of the body's alternative cellular energy (ACE) pathway will lead to expedited healing of active herpes simplex virus (HSV) and herpes zoster virus (HZV)skin lesions, and also possibly inhibit both latent HSV infections and residual HZV infections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2008
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 19, 2008
CompletedFirst Posted
Study publicly available on registry
March 25, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2008
CompletedJune 3, 2008
May 1, 2008
3 months
March 19, 2008
May 30, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Expedited healing of active lesions
Within 1 day following therapy
Secondary Outcomes (1)
Recurrence of lesions and/or symptoms
3 months
Study Arms (4)
1
Patients with active oral or genital HSV skin lesions
2
Patients with a history of recurrent oral or genital HSV but without an active lesion at the time of treatment
3
Patients with active shingles/zoster
4
Patients with post herpetic neuralgia
Eligibility Criteria
HSV and HZV infected patients
You may qualify if:
- Clinical diagnosis of active, latent or residual HSV or HZV infection
You may not qualify if:
- Unwilling or unable to provide Informed Consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Martin WJ, Stoneburner J. Symptomatic relief of herpetic skin lesions utilizing an energy-based approach to healing. Exp Mol Pathol. 2005 Apr;78(2):131-4. doi: 10.1016/j.yexmp.2004.10.007. Epub 2005 Jan 5.
PMID: 15713438BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
W John Martin, MD, PhD
Institute of Progressive Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 19, 2008
First Posted
March 25, 2008
Study Start
January 1, 2008
Primary Completion
April 1, 2008
Study Completion
April 1, 2008
Last Updated
June 3, 2008
Record last verified: 2008-05